Cargando…

Antiangiogenic therapies in urogenital malignancies: Fiction or fact?

The use of antiangiogenic agents in cancer therapy has become an attractive target in oncological research. However, concerning the uro-oncological field, current guidelines only recommend the use of antiangiogenic agents in metastatic renal cell cancer. Yet in recent years, several approaches for s...

Descripción completa

Detalles Bibliográficos
Autores principales: Haidl, Friederike, Pfister, David, Heidenreich, Axel, Heidegger, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725505/
https://www.ncbi.nlm.nih.gov/pubmed/29250197
http://dx.doi.org/10.1007/s12254-017-0375-8